missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Indoles and derivatives
  7. Oncrasin 1, Tocris Bioscience™

Oncrasin 1, Tocris Bioscience™

Product Code. 18075582
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Induces abnormal nuclear aggregation of PKCι; proapoptotic

Proapoptotic agent that induces abnormal nuclear aggregation of PKCι and suppresses RNA transcription. Exhibits antiproliferative effects against various human tumor cell lines with K-Ras mutations (IC50 ≤ 3 μM) with minimal effects on normal epithelial cells and inhibits human xenograft growth by 75% in vivo.
TRUSTED_SUSTAINABILITY

Chemical Identifiers

CAS 75629-57-1
Molecular Formula C16H12ClNO
Molecular Weight (g/mol) 269.73
MDL Number MFCD01051808
InChI Key ZDRQMXCSSAPUMM-UHFFFAOYSA-N
Synonym oncrasin-1, 1-4-chlorobenzyl-1h-indole-3-carbaldehyde, oncrasin 1, 1-4-chlorophenyl methyl indole-3-carbaldehyde, 1-4-chlorophenyl methyl-1h-indole-3-carboxaldehyde, 1-4-chloro-benzyl-1h-indole-3-carbaldehyde, oncrasin1, cambridge id 5601604, n-4-chlorobenzyl-3-formylindole, oncrasin hplc
PubChem CID 872445
IUPAC Name 1-[(4-chlorophenyl)methyl]-1H-indole-3-carbaldehyde
SMILES ClC1=CC=C(CN2C=C(C=O)C3=CC=CC=C23)C=C1

Specifications

Quantity 10 mg
Formula Weight 269.73
Percent Purity >98%
Chemical Name or Material Oncrasin 1
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.